CBD Shows Promise in Lab But Fails to Beat Placebo for Cocaine Addiction
Despite promising preclinical results, a scoping review found that clinical trials of CBD for cocaine use disorder showed no significant benefit over placebo for craving, relapse, or cognitive function.
Quick Facts
What This Study Found
Clinical studies did not demonstrate significant efficacy of CBD over placebo in reducing cocaine craving, preventing relapse, or improving cognitive performance. However, CBD was well tolerated and had fewer adverse events than conventional treatments. The gap between preclinical promise and clinical reality highlights methodological challenges.
Key Numbers
CBD was well tolerated across all clinical trials. No significant efficacy over placebo for: cocaine craving, relapse prevention, cognitive performance. Key limitations: variability in dosage, treatment duration, and study design across trials.
How They Did This
Scoping review synthesizing clinical trial evidence on CBD for cocaine use disorder. Evaluated effects on craving reduction, relapse prevention, cognitive function, and emotional regulation. Assessed methodological quality and identified research gaps.
Why This Research Matters
This is a cautionary tale for translating preclinical cannabis research: what works in animal models doesn't always work in humans. Cocaine addiction desperately needs new treatments, and while CBD's safety profile is encouraging, its efficacy remains unproven.
The Bigger Picture
This negative finding is actually valuable — it prevents false hope and redirects research toward potentially more effective approaches, such as combining CBD with behavioral therapy or other medications rather than using it as a standalone treatment.
What This Study Doesn't Tell Us
Scoping review (not systematic with meta-analysis). Small number of clinical trials available. Heterogeneous dosing and study designs make comparison difficult. Short treatment durations may miss delayed effects.
Questions This Raises
- ?Would higher or longer CBD dosing help?
- ?Could CBD work better as part of a multimodal treatment?
- ?Are there specific subgroups of cocaine users who might respond to CBD?
Trust & Context
- Key Stat:
- Evidence Grade:
- Scoping review of clinical trials showing consistent null results — informative negative finding with implications for research direction.
- Study Age:
- Published in 2026, providing an updated assessment of CBD for cocaine addiction.
- Original Title:
- Cannabidiol as a treatment for cocaine use disorder: a scoping review.
- Published In:
- Naunyn-Schmiedeberg's archives of pharmacology (2026)
- Authors:
- Dos Santos, Leticia Custódio, da Cunha, Verônica Barros, Ribeiro, Jéssyca Milene, Torres, Larissa Helena Lobo, Garcia, Raphael Caio Tamborelli
- Database ID:
- RTHC-08234
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Can CBD treat cocaine addiction?
Current evidence says no — clinical trials found CBD was no better than placebo for reducing cocaine cravings or preventing relapse, despite promising results in animal studies. It may have potential as part of combination therapy, but not as a standalone treatment.
Why does CBD work in animals but not humans for cocaine addiction?
The gap likely reflects differences in dosing, timing, and the complexity of human addiction. Animal models can't capture social, psychological, and environmental factors that drive human drug use.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08234APA
Dos Santos, Leticia Custódio; da Cunha, Verônica Barros; Ribeiro, Jéssyca Milene; Torres, Larissa Helena Lobo; Garcia, Raphael Caio Tamborelli. (2026). Cannabidiol as a treatment for cocaine use disorder: a scoping review.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05037-x
MLA
Dos Santos, Leticia Custódio, et al. "Cannabidiol as a treatment for cocaine use disorder: a scoping review.." Naunyn-Schmiedeberg's archives of pharmacology, 2026. https://doi.org/10.1007/s00210-026-05037-x
RethinkTHC
RethinkTHC Research Database. "Cannabidiol as a treatment for cocaine use disorder: a scopi..." RTHC-08234. Retrieved from https://rethinkthc.com/research/dos-2026-cannabidiol-as-a-treatment
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.